Login / Signup

Ranibizumab for Macular Edema Secondary to Central and Branch Retinal Vein Occlusion in Patients Younger Than 50 Years of Age.

Maurizio Battaglia ParodiFrancesco RomanoAlessandro ArrigoStefano MercuriAlessandro FranceschiFrancesco Maria Bandello
Published in: BioMed research international (2020)
Our study indicates that IVR injections can be a valid therapeutic option in patients under 50 years of age with ME secondary to RVO.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • diabetic retinopathy
  • prognostic factors
  • optical coherence tomography
  • patient reported outcomes
  • age related macular degeneration